New Delhi: Every wave of Pandemic Covid-19 has a star narcotics share promising potential drugs.
While the first wave has everything starting from malaria drugs to antivirus, the second has remdesivir.
In the middle of the third wave, there are monoclonal antibodies and antiviral drugs called Molnupiravir.
This drug is very popular, even though the benefits are limited.
Monoclonal antibodies are molecules developed in the laboratory designed to emulate or increase the response to the natural immune system against invaders, such as cancer or infection.
SARS COV2, a virus that causes covid, has a surge protein on its surface that helps viruses stick to human cells.
Monoclonal antibodies have been developed to tie a protein to surge the virus and prevent it from invading human cells.
Also reading, the omicron variant of January Fuel Covid Surge in Delohe the latest report from positive covid samples analyzed in the Delhi genome sequencement laboratory proves what medical experts say for some time – a major surge in new cases driven by the Omicron variant.
Novel Coronavirus.Dr Sumit Ray, Chief of Critical Care, Holy Family Hospital, said monoclonal antibodies available in India were not effective against the omicron variant of Coronavirus.
“We have used it in six or seven patients, most of them suffer from covids caused by Delta variants,” he said.
For this, Dr.
Rajesh Malhotra, head of the AIIMS trauma center, added that monoclonal antibodies have proven effective in the initial treatment of delta infections by preventing serious complications and deaths, especially in elderly patients or patients with comorbidity.
However, because Omicron has demonstrated the ability of immune hitch, the meaning of resistance to vaccines and antibodies, monoclonal antibodies is not effective.
“There is no reason to use this in the current wave,” said Malhotra.
“The only combination antibody treatment for Omicron is Evusheld and Sotrovimab.” Molnupiravir is a new molecule that acts with the genetic virus genetic material and stops replication by causing mutations, explaining Dr Neeraj Nischal, additional medical professors, AIIMS.
“The population subset where the trial was carried out during Delta waves only showed a small risk reduction in hospitalization, translated, therefore, with simple benefits in today’s real world scenario (omicron wave) to the potential toxicity that can be caused by the patient.,” He said.
Read the Alsodelhi Government will provide free online yoga lessons to Covid patients, said CM Arvind Kejriawief Minister Arvind Kejriwal on Tuesday announced that the Delhi government would provide free online yoga and pranayama lessons to Covid-19 patients recovering in isolation.
Kejriwal said the classes would be held in batch 15, with sufficient instructors to care for 40,000 patients, especially in reproductive organs, bone tissue and cartilage in young individuals.
“Therefore, we warn their use in men and women of reproductive age and in children less than 18 years old, pregnant and breastfeeding mothers.
This is clearly not a magical pill to prevent or treat Covid-19 and should not be used indiscriminately, “Nischal said.
Read Alsocovid-19: 3.5 Lakh Students vaccinated in Delhi, focus now on Teens Out-of-school a total of 3.5 lakh teenagers have received their first covaxin dose.
Tuesday is the ninth day since vaccination beneficiaries in the age group 15-17 years begin “for patients with mild symptoms in house isolation, we do not need an aggressive management strategy.
Paracetamol and anti-allergic drugs may be sufficient if there are symptoms such as fever and Sore throat.
For patients who are hospitalized, steroids, anticoagulants, antivirus drugs or immunosuppressants may be needed, “said Kansal, which is a senior consultant in the Department of Respiratory Medicine and critical care at Apollo Hospital.
Dr.
Kumar, Medical Director of the Lok Nayak Hospital, also said steroids, remediesivir and Todilizumab remain a drug for heavy covid cases.
Why no magic pill for Covid-19
